Mail

UK markets close in 4 hours 20 minutes

FTSE 100
8,250.95
+3.16(+0.04%)
FTSE 250
20,353.51
-9.92(-0.05%)
AIM
767.02
-1.01(-0.13%)
GBP/EUR
1.1842
+0.0004(+0.04%)
GBP/USD
1.2654
-0.0033(-0.26%)
Bitcoin GBP
48,526.72
+50.80(+0.10%)

The cost of following England at Euro 2024

What could your money earn if you invested your football spending elsewhere

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY

Add to watchlist

15.69

+0.33

(+2.15%)

At close: 03:04PM CST

Currency in CNY

Valuation measures⁴

Market cap (intra-day)	25.66B
Enterprise value	25.78B
Trailing P/E	56.55
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.88
Price/book (mrq)	2.18
Enterprise value/revenue	2.89
Enterprise value/EBITDA	40.34

Trading information

Stock price history

Beta (5Y monthly)	0.20
52-week change ³	-39.60%
S&P500 52-week change ³	24.96%
52-week high ³	27.25
52-week low ³	15.23
50-day moving average ³	18.50
200-day moving average ³	21.44

Share statistics

Avg vol (3-month) ³	11.74M
Avg vol (10-day) ³	11.53M
Shares outstanding ⁵	1.67B
Implied shares outstanding ⁶	1.7B
Float ⁸	379.99M
% held by insiders ¹	58.31%
% held by institutions ¹	4.38%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.5
Forward annual dividend yield ⁴	3.26%
Trailing annual dividend rate ³	0.30
Trailing annual dividend yield ³	1.95%
5-year average dividend yield ⁴	1.65
Payout ratio ⁴	184.09%
Dividend date ³	N/A
Ex-dividend date ⁴	17 Jul 2023
Last split factor ²	1.4:1
Last split date ³	07 Jul 2021

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	5.09%
Operating margin (ttm)	14.44%

Management effectiveness

Return on assets (ttm)	1.81%
Return on equity (ttm)	3.73%

Income statement

Revenue (ttm)	8.91B
Revenue per share (ttm)	5.33
Quarterly revenue growth (yoy)	-35.90%
Gross profit (ttm)	N/A
EBITDA	1.08B
Net income avi to common (ttm)	453.79M
Diluted EPS (ttm)	0.27
Quarterly earnings growth (yoy)	-74.70%

Balance sheet

Total cash (mrq)	1.3B
Total cash per share (mrq)	0.78
Total debt (mrq)	1.42B
Total debt/equity (mrq)	12.07%
Current ratio (mrq)	1.55
Book value per share (mrq)	7.03

Cash flow statement

Operating cash flow (ttm)	-127.88M
Levered free cash flow (ttm)	28.05M